<DOC>
	<DOCNO>NCT00063635</DOCNO>
	<brief_summary>The purpose study determine therapeutic modification insulin resistance oxidative stress lead improvement serum histologic indicator liver injury quality life .</brief_summary>
	<brief_title>Treatment Nonalcoholic Fatty Liver Disease Children ( TONIC )</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 817 year first screen visit Histologic evidence Nonalcoholic Fatty Liver Disease ( NAFLD ) biopsy old 6 month randomization ALT level &gt; 60 U/L time screen one previous occasion determine least one month great 6 month prior screen ALT Consent</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Non alcoholic fatty liver disease</keyword>
</DOC>